SG11202108111WA - Recombinant nucleic acids containing alphaherpesvirus promoter sequences - Google Patents

Recombinant nucleic acids containing alphaherpesvirus promoter sequences

Info

Publication number
SG11202108111WA
SG11202108111WA SG11202108111WA SG11202108111WA SG11202108111WA SG 11202108111W A SG11202108111W A SG 11202108111WA SG 11202108111W A SG11202108111W A SG 11202108111WA SG 11202108111W A SG11202108111W A SG 11202108111WA SG 11202108111W A SG11202108111W A SG 11202108111WA
Authority
SG
Singapore
Prior art keywords
cell
seq
nucleic acid
acid sequence
promoter
Prior art date
Application number
SG11202108111WA
Other languages
English (en)
Inventor
Esteban Engel
Carola Maturana
Lynn Enquist
Original Assignee
Univ Princeton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Princeton filed Critical Univ Princeton
Publication of SG11202108111WA publication Critical patent/SG11202108111WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
SG11202108111WA 2019-02-05 2020-02-05 Recombinant nucleic acids containing alphaherpesvirus promoter sequences SG11202108111WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962801524P 2019-02-05 2019-02-05
US201962950848P 2019-12-19 2019-12-19
PCT/US2020/016787 WO2020163475A1 (en) 2019-02-05 2020-02-05 Recombinant nucleic acids containing alphaherpesvirus promoter sequences

Publications (1)

Publication Number Publication Date
SG11202108111WA true SG11202108111WA (en) 2021-08-30

Family

ID=71947095

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108111WA SG11202108111WA (en) 2019-02-05 2020-02-05 Recombinant nucleic acids containing alphaherpesvirus promoter sequences

Country Status (11)

Country Link
US (1) US12551574B2 (enExample)
EP (1) EP3921431A4 (enExample)
JP (2) JP7658580B2 (enExample)
KR (1) KR20210125014A (enExample)
CN (1) CN113383082A (enExample)
AU (1) AU2020218337A1 (enExample)
BR (1) BR112021015281A2 (enExample)
CA (1) CA3127019A1 (enExample)
MX (1) MX2021009161A (enExample)
SG (1) SG11202108111WA (enExample)
WO (1) WO2020163475A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7658580B2 (ja) 2019-02-05 2025-04-08 ザ、トラスティーズ オブ プリンストン ユニバーシティ アルファヘルペスウイルスプロモーター配列を含む組換え核酸
US20250025575A1 (en) * 2021-11-23 2025-01-23 The Trustees Of Princeton University Compositions and Methods for Cell-Specific Expression of Target Genes
WO2026032009A1 (en) * 2024-08-06 2026-02-12 Chinese Institute For Brain Research, Beijing (Cibr) A microglia-specific regulatory element for aav-mediated transgene manipulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352596A (en) * 1992-09-11 1994-10-04 The United States Of America As Represented By The Secretary Of Agriculture Pseudorabies virus deletion mutants involving the EPO and LLT genes
US7341847B2 (en) * 2003-04-02 2008-03-11 Agency For Science, Technology And Research Promoter construct for gene expression in neuronal cells
WO2005080581A2 (en) * 2004-02-17 2005-09-01 University Of Florida Research Foundation, Inc. Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression
EP2058401A1 (en) 2007-10-05 2009-05-13 Genethon Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
JP7090548B2 (ja) 2016-01-29 2022-06-24 ジリオン バイオテック ゲーエムベーハー Ａａｖ系条件的発現系
JP7658580B2 (ja) 2019-02-05 2025-04-08 ザ、トラスティーズ オブ プリンストン ユニバーシティ アルファヘルペスウイルスプロモーター配列を含む組換え核酸
US20250025575A1 (en) 2021-11-23 2025-01-23 The Trustees Of Princeton University Compositions and Methods for Cell-Specific Expression of Target Genes

Also Published As

Publication number Publication date
EP3921431A1 (en) 2021-12-15
CA3127019A1 (en) 2020-08-13
JP7658580B2 (ja) 2025-04-08
WO2020163475A1 (en) 2020-08-13
JP2025026584A (ja) 2025-02-21
JP2022518867A (ja) 2022-03-16
BR112021015281A2 (pt) 2021-10-05
EP3921431A4 (en) 2022-12-14
CN113383082A (zh) 2021-09-10
KR20210125014A (ko) 2021-10-15
MX2021009161A (es) 2021-09-10
US12551574B2 (en) 2026-02-17
US20220378941A1 (en) 2022-12-01
AU2020218337A1 (en) 2021-08-26

Similar Documents

Publication Publication Date Title
ES2946747T3 (es) Variantes de cápsides de virus adenoasociado y su utilización para inhibir la angiogénesis
JP7205933B2 (ja) ハンチントン病のａａｖ処置
CN109641939B (zh) 变体腺伴随病毒及使用方法
ES2941502T3 (es) Variantes de cápsides de virus adenoasociado y procedimientos de utilización de las mismas
US11364309B2 (en) Neuronal enhancers
US20180245073A1 (en) Regulatable expression using adeno-associated virus (aav)
KR20200051708A (ko) 비-바이러스성 캡시드-비함유 dna 벡터의 지질 나노입자 제형
JP2025026584A (ja) アルファヘルペスウイルスプロモーター配列を含む組換え核酸
JP2024109708A (ja) 非症候性感音性聴力喪失の治療方法
Maturana et al. Small alphaherpesvirus latency-associated promoters drive efficient and long-term transgene expression in the CNS
CN112680443A (zh) 一种启动子pCalm1及其应用
JP2023153320A (ja) Ｃｌｒｎ１に関連する聴力喪失及び／または視力喪失を治療する方法
WO2025212993A1 (en) Materials and methods for trangene expression in neural cells
US20230279405A1 (en) Dna-binding domain transactivators and uses thereof
KR20230146560A (ko) 하이브리드 aav-아넬로벡터
JP2023544264A (ja) 核酸構築物、ウイルスベクター及びウイルス粒子
US20250025575A1 (en) Compositions and Methods for Cell-Specific Expression of Target Genes
Galvan et al. MiniPromoters Ple384 (TH) and Ple388 (PITX3) for targeting midbrain dopaminergic neurons in mice and monkeys
CN118853669A (zh) 一种增强肌肉特异性基因表达的增强子及其用途
CN121699948A (zh) 筛选或评价亨廷顿病药物的方法
HK40109651A (en) Recombinant tert-encoding viral genomes and vectors
EA044679B1 (ru) Вариантные аденоассоциированные вирусы и способы их применения